Context: Increased evening cortisol levels have been implicated in bone mineral density (BMD) loss. The effect on bone microarchitecture and fracture risk has never been studied.
low-cumulative doses, and is associated with an increased risk of fractures. This increased fracture risk is poorly correlated with bone mineral density (BMD) in GIOP (3) . Glucocorticoids (GCs) induce well-known changes in different parameters of microarchitecture (4) . In the clinical setting, trabecular bone score (TBS) is a parameter of bone texture derived from the lumbar spine dual X-ray absorptiometry (DXA) image that correlates to bone microarchitecture independently of site matched BMD and clinical risk factors (5, 6 ). Patients with a high level of endogenous GCs or treated with GCs have a low TBS but less significantly decreased BMD (7) (8) (9) (10) (11) . This effect on microarchitecture, indirectly assessed by TBS, has also been shown in subclinical hypercortisolism (12) . The risk of fracture in GIOP is reversible after treatment discontinuation (13) . In patients with treated Cushing's disease, TBS increases as much as 6.9% and 13.8% at 1 and 2 years, respectively, vs 3.1% and 2.2% for lumbar BMD, suggesting a potential role of microarchitecture in the decrease of fracture risk (10) .
Cortisol exhibits a marked diurnal rhythm synchronized to awakening (14) . With aging, earlier morning cortisol peak and late-day and evening higher nadir values are observed (2, 15) . Salivary cortisol, an easy and nonstressfully method of cortisol measurement, showed the same changes in cortisol circadian rhythm with aging as serum measurements (16) . Circadian bone turnover pattern is inversely correlated with cortisol circadian rhythm with a time lag of about 4 hours. Circadian rhythm of bone formation (but not of bone resorption) can be modified by changing cortisol circadian rhythm (17) (18) (19) .
The close relationship between bone remodeling and cortisol circadian rhythm has led to the hypothesis that changes in cortisol circadian rhythm with aging could be at the origin of BMD loss by representing an increased corticotropic axis activity. Several studies showed that endogenous cortisol profile, either assessed by serum measurement (20) , dynamic testing of the corticotropic axis (21) , salivary cortisol assessment (22, 23) , and/or by urinary free cortisol (24) , is a determinant of BMD and/or of the rate of bone loss. Moreover, it could also be the mediator of the decreased BMD observed in patients suffering from mental disorders, notably depression both in premenopausal (25) and postmenopausal women (26) . However, the populations studied were either of small size or heterogeneous (men and pre-or postmenopausal women). No study has addressed the role of cortisol circadian rhythm changes on microarchitecture alteration neither on fracture prevalence.
We hypothesized that, in a large cross-sectional, population-based study on osteoporosis in women conducted in Lausanne, Switzerland, higher evening levels of salivary cortisol were associated with decreased TBS and increased prevalent fractures. We aimed to determine whether the effects of higher evening cortisol levels on fracture prevalence, when confirmed, were correlated to lower TBS values.
Materials and Methods

Sampling procedure
Data from the OsteoLaus study were used (27) . OsteoLaus is a substudy of the CoLaus/PsyColaus study, an ongoing prospective study aiming to assess the determinants of cardiovascular and psychiatric diseases using a population-based sample drawn from the city of Lausanne (27, 28) . Briefly, recruitment took place between June 2003 and May 2006 and the target sample were all inhabitants of the city of Lausanne aged between 35 and 75 years. The initial sample was 6733; the first follow-up was conducted between 2009 and 2013 and included 5064 subjects who participated in the physical evaluation and 4004 subjects who participated in the psychiatric evaluation ( Fig. 1) . Between September 2009 and September 2012, all women aged between 50 and 80 years from the CoLaus/PsyCoLaus study (first follow-up) were invited to participate in the OsteoLaus study, and 85% accepted (Fig. 1) . The aims of the OsteoLaus study are to compare different models of fracture risk prediction and to assess the relationship between osteoporosis and cardiovascular diseases. At the first follow-up, participants in the psychiatric evaluation benefited from an assessment of the corticotropic axis by measures of salivary cortisol circadian rhythm.
The Institutional Ethics Committee of the University of Lausanne approved the CoLaus/PsyCoLaus and, subsequently, the OsteoLaus studies. All participants signed a written informed consent form after having received a detailed description of the goal and funding of the studies.
Participants
Of the 1500 women recruited to the OstoLaus Cohort, 753 (50.2%) had at least one salivary cortisol measure. From those, 145 presented one or more exclusion criteria: current or previous systemic GC treatment $3 months (n = 27), noninterpretable lumbar spine images [n = 28: extreme body mass index (BMI), defined as ,15 kg/m 2 or .37 kg/m 2 ; severe spine deformations, osteosynthesis material, less than two evaluable vertebrae], and/or current smoker (n = 102). This subcohort finally included 608 participants to be analyzed.
Measurements: covariates
At baseline (the first OsteoLaus visit), each patient had (1) a questionnaire on potential clinical risk factors for fracture/ osteoporosis (including Swiss FRAX ® assessment) and on conditions affecting bone metabolism, (2) a spine (L1 to L4) and femur DXA scan using the Discovery A System (Hologic, Waltham, MA), (3) a blind central processing of TBS (TBS iNsight v2.1, Medimaps, Mérignac, France) based on the previously acquired anteroposterior spine DXA scan, and (4) a vertebral fracture (VFx) assessment by two experimented clinicians using the semiquantitative approach of Genant et al. (29) . Spine and femur DXA were analyzed according to the International Society for Clinical Densitometry recommendations (30) . TBS calculation includes a partial correction to tissue thickness. The diagnosis of VFx was given only for grades 2 and 3.
Data used from CoLaus/PsyCoLaus study included personal and treatment history data. Venous blood samples were drawn after an overnight fast, and calcium and albumin chemistry assays were performed by our Clinical Laboratory on fresh blood samples. Corrected calcium for albumin was calculated using the following formula: corrected Ca = [0.8 3 (40 -participant's albumin)] + serum Ca level.
To determine the influence of clinical conditions and treatments not included in the FRAX © risk score, we defined as covariates, respectively, current calcium or vitamin D supplements intake, current or previous osteoporosis treatments (bisphosphonates, raloxifen, teriparatide, strontium ranelate, and denosumab), current or previous estrogen substitution (all oral or transdermal preparations), other current known bone beneficial treatments (dehydroepiandrosterone, tamoxifen, hydrochlorothiazide), current bone deleterious treatments (serotonin uptake inhibitors, antiepileptics, proton pump inhibitors, pioglitazone, tenofovir, antiaromatases, progesterone-only contraception, and ciproterone acetate), and history of diseases negatively affecting bone health not specifically included in the FRAX © calculation (hyperthyroidism, diabetes, malabsorption, hypogonadism, and hyperparathyroidism). Diabetes was defined as a fasting glucose of 7.0 mmol/L or being on antidiabetic medication and/or insulin.
Measurements: salivary cortisol
Salivary cortisol measures were performed during the psychiatric assessment (31) . Briefly, at the end of the interview, participants received little swabs (Salivettes, Sarstedt, Sevelen, Switzerland) to be used for salivary cortisol collection on a working day at awakening, 30 minutes thereafter, at 11 AM, and at 8 PM; there were 0, 25, 20, and 23 missing samples for each timepoint, respectively. Subjects were instructed not to brush their teeth and to refrain from eating, drinking, smoking, and exercising 30 minutes prior to and during the sampling procedure (32) . Until sampling had been completed, subjects stored the saliva samples at home in their freezers before returning them to the laboratory, where they were stored at -20°C until biochemical analysis. Free cortisol levels were measured using a commercially available chemiluminescence assay (IBL, Hamburg, Germany). Inter-and intra-assay coefficients of variability were ,9%.
For each analysis, salivary cortisol values .4 standard deviations (SDs) higher than the mean (0, 0, 1, and 2 participants respectively for awakening, 30 minutes thereafter, 11 AM, and at 8 PM) were considered as outliers and were excluded. For each salivary cortisol measure, the final number of analyzed values depended on the number of missing and outlier samples for the specific measure. For example, at 8 PM, of the 608 participants included, two were excluded for salivary cortisol values .4 SD over the mean and 23 were excluded for missing samples, so 583 cortisol measures were analyzed.
Statistical analysis
Statistical analyses were conducted using Stata v14 © (StataCorp, College Station, TX) for Windows © . Descriptive results are expressed as number of participants (percentage) or as average 6 SD. First, for salivary cortisol values analysis, participants were classified by tertiles of age. Secondly, to analyze the effect of salivary cortisol values on bone parameters, they were classified by tertiles of salivary cortisol values at each timepoint. Estimated cut-point of 8 PM salivary cortisol (sc-8 PM), inducing an increased risk for VFx, was determined using the Liu method (33) . The diagnostic accuracy of each marker was assessed by computing the receiver operating characteristic (ROC) curve and corresponding areas under the ROC curve.
Univariate analyses were conducted using x 2 or Fisher's exact test for categorical variables and analysis of variance for quantitative variables. Multivariate models were applied using analysis of variance for continuous variables, and results are expressed as adjusted average 6 standard error; posthoc bivariate comparisons were conducted using the Bonferroni method. For categorical variables, multivariate modeling was performed by logistic regression and results were expressed as odds ratio (95% confidence interval). Logistic regression was done after log-transformation of salivary cortisol values to obtain a normal distribution. Adjustments were performed for age (continuous); BMI (continuous); calcium corrected for albumin (continuous); minutes of walking per week (continuous); calcium supplements (yes/no); vitamin D supplements (yes/no); estrogen substitution (yes/no); osteoporosis treatment (yes/ no); bone-affecting treatments, deleterious (yes/no) or beneficial (yes/no); and bone affecting diseases (yes/no). Statistical significance was considered for a two-sided test with P , 0.05.
Results
The baseline characteristics of the 753 participants are given in Table 1 . Characteristics of the 583 included and the 170 excluded participants (145 applying general exclusion criteria, 23 missing samples, two outliers) according to the analysis by tertiles of sc-8 PM are also detailed.
Excluded participants are slightly younger and have higher BMI. sc-8 PM is significantly higher. They have more bone-affecting diseases and lower TBS.
Salivary cortisol values According to age
For salivary cortisol analysis, participants were classified by tertiles of age. Baseline characteristics (Supplemental Table 1 ) and bone health parameters (Supplemental Table 2 ) showed, as expected, that older women are more frequently taking calcium supplements, and have more frequently received estrogen substitution or osteoporosis treatment. Older women have lower total hip BMD and lumbar TBS and a tendency for higher number of radiological grade 2 and 3 VFx and all nontraumatic fractures.
We observed higher values of salivary cortisol in the highest tertile of age for both 11 AM and 8 PM measures (Table 2 ). This effect persisted even after a multivariate model on all the described variables in Table 1 was applied (results not shown).
Salivary cortisol values at 8 PM are associated to bone health parameters Participants were classified by tertiles of salivary cortisol at each time-point (after exclusion of values .4 SD higher than the mean); characteristics of the sample, overall and according to sc-8 PM tertiles, are depicted in Table 3 . Bone health parameters were not related to salivary cortisol values at awakening, 30 minutes thereafter, or at 11 AM, neither in univariate analysis nor in covariate analysis with the variables described, including the FRAX © calculated risk (results not shown).
On the contrary, in the univariate analysis, participants with higher sc-8 PM were slightly (but statistically significantly) older (Table 3) , had lower TBS, and more prevalent grade 2 and 3 VFx and clinical low-traumatic fractures (results not shown). Same results were obtained when applying a multivariate model, except that (Tables 3 and 4) .
Prevalence of vertebral fractures is independently associated to both higher sc-8 PM and lower TBS values
As depicted in Fig. 2 , there was an inverse linear relationship between sc-8 PM and TBS, each 1-log increase in sc-8 PM inducing a highly significant decrease of 0.052 (0.020 to 0.085) in TBS (P = 0.002).
To determine whether the increased fracture prevalence in participants with higher sc-8 PM was related to lower TBS values or to age, we performed multivariate modeling. The analysis confirmed the independent association of prevalent VFx grade 2 and 3 with sc-8 PM (P = 0.001), as well as with TBS (P = 0.023), without any effect of age (P = 0.469) or lumbar spine BMD (P = 0.345). On the contrary, in the multivariate model, all nontraumatic fractures and major osteoporotic fractures were correlated only to TBS (P , 0.001) and no longer to sc-8 PM (P = 0.453 and P = 0.139, respectively), neither for age (P = 0.294 and P = 0.289, respectively) nor for lumbar spine BMD (P = 0.128 and P = 0.289, respectively). We estimated a cut-point for sc-8 PM that correlates with the presence of at least one VFx at 3.62 nmol/L, with a sensitivity of 0.74 and a specificity of 0.66. ROC analysis comparing the calculated optimal cut-point to the cutoff value between tertiles 1 and 2, and 2 and 3, showed that it significantly has the highest area under the curve (P = 0.046 for the comparison of the three areas under the ROC curve).
Discussion
In this population-based study of women .50 years old, older women have higher salivary cortisol values at 11 AM and 8 PM. Higher salivary cortisol values at 8 PM are independently associated with lower TBS values and increased prevalence of radiologic VFx.
We do not know which factors induce higher values of sc-8 PM in participants included in the third sc-8 PM tertile. Salivary cortisol levels at both 11 AM and 8 PM are higher in the highest tertile of age, but increased sc-8 PM values were independent of age. Salivary cortisol measure between 11 PM to 12 PM is used for diagnosis of overt Cushing's syndrome with threshold values between 2.8 to 15.2 nmol/L, depending on the assay and on the reference population (34) . Our values in sc-8 PM tertile 3 range between 3.7 and 22.5 nmol/L. There were no participants with Cushing syndrome, and we excluded those with current or previous GC treatment. We also reasonably excluded participants with pathologies that lead to pseudo-Cushing states: there was no participant known for chronic alcoholism or decompensated diabetes, and those with severe obesity were excluded. Moreover, for the included participants, there was no association between BMI and salivary cortisol values. It is possible that some of the participants in sc-8 PM tertile 3 suffer from subclinical hypercortisolism; however, subclinical hypercortisolism prevalence in the general population is low, from 0.1% to 1.6% (35) . Finally, current smokers were excluded because smoking interferes with cortisol production and salivary cortisol circadian rhythm values (36) . The analysis of social or psychological-related parameters that could lead to an increased functionality of the corticotropic axis is beyond the scope of this study.
Our results are in agreement with data from smaller studies suggesting that increased corticotropic axis activity, due to aging or psychological stress, has a negative effect on bone health parameters (20-26). These published studies are heterogeneous for many reasons:
(1) the population studied (premenopausal and postmenopausal women, and men), (2) the corticotropic axis assessment method (morning serum cortisol measurement, dynamic testing of the corticotropic axis, free urinary cortisol, or salivary cortisol measures), and (3) the bone health parameter studied (BMD, osteoclast or osteoblast activity measured by serum or urine biomarkers). Only three of them assessed the corticotropic axis by measuring evening salivary cortisol in postmenopausal women (22, 24, 26) . One showed an association between 11 PM salivary cortisol level and lumbar BMD, specifically in postmenopausal women without hormonal replacement therapy (22) , and another between the salivary cortisol response to stress and lumbar and hip BMD [but not basal salivary cortisol values (26)]. The third one (24) did not show any association to BMD. None of them studied the relationship neither to microarchitecture nor to fracture risk. We showed for the first time in patients without excess of endogenous GCs that changes cortisol circadian rhythm (increased evening cortisol) are independently associated to lower TBS values and to increased prevalence of VFx grade 2 and 3, as suggested by studies in subclinical hypercortisolism (12) . In our cohort, there is no association between sc-8 PM and lumbar spine or hip BMD, but with lumbar spine TBS, which is a surrogate marker of microarchitecture. The different effect of endogenous or exogenous GCs on TBS and BMD was described in many studies (7) (8) (9) (10) (11) (12) , and the presence of subclinical hypercortisolism in patients known for an adrenal incidentaloma has been correlated to lower TBS (19) . In our study, there is an inverse linear relationship between sc-8 PM and TBS. Nevertheless, it is a weak association, and it is probably not relevant in individual cases.
TBS has been shown to be associated with an increase in both prevalent and incident fractures independently of both clinical risk factors and BMD at the lumbar spine and proximal femur (6, 37) . We therefore analyzed whether the increased VFx risk in higher sc-8 PM may be due to the TBS decrease. However, multivariate modeling shows that both parameters remained significant into the VFx risk model, demonstrating that effect of sc-8 PM is not entirely mediated by TBS, and conversely. On the contrary, neither age nor increased sc-8 PM is associated with increased prevalence of all nontraumatic fractures or of major osteoporotic fractures in the multivariate model. This is not surprising, as it is well known that the main consequence of glucocortidoid excess is an increase in VFx risk (3) , and subclinical hypercortisolism is associated to increased risk of osteoporosis and VFx. We can conclude that measuring both sc-8 PM and TBS may be important to determine VFx risk in a healthy population.
Older age is one of the most important risk factor for VFx in epidemiological studies (1) . In our study, women with highest values of sc-8 PM are only slightly older than those with lowest values (mean age = 66.4 vs 64.2 years old), also suggesting that the increased prevalence of VFx with higher values of sc-8 PM is not associated to older age. To note, the slight increased prevalence of MOF (major osteoporotic fractures) in older participants does not reach significance (Supplemental Table 2 ). This hypothesis is confirmed by the multivariate model in which sc-8 PM, but not age, is associated with VFx prevalence. Also, the mean sc-8 PM in third cortisol tertile is higher than the mean sc-8 PM in the third age tertile (5.7 6 2.5 vs 3.8 6 2.7), suggesting that cortisol values increase is not only due to increasing age. Finally, the estimated cutpoint of sc-8 PM, which correlates with the presence of at least one VFx, 3.62 nmol/L, is close to the mean value in the highest age tertile (3.8 6 2.7). Indeed, even in the highest age tertile, participants in highest vs lowest sc-8 PM tertile have increased prevalence of VFx (12.3% vs 1.5%; Fisher's exact test = 0.046). Altogether, these data suggest that sc-8 PM is associated to radiologic VFx independent of age.
Our results suggest that the effect of increased sc-8 PM on bone health may be as important as aging. TBS is lower in the third tertile of age (1.25 6 0.10) than in the third tertile of sc-8 PM (1.27 6 0.10), so that the fracture prevalence is the same in both groups. However, although the relative increase of sc-8 PM is similar between tertiles 1 and 2 and tertiles 2 and 3 (about 31.8), the significant increase in VFx is only observed on the highest values of tertile 3, which also show the highest loss of TBS (loss of 0.006 points between tertiles 1 and 2, vs loss of 0.023 between tertiles 2 and 3 in the multivariate model), suggesting there is a cut-point value for sc-8 PM from which there is an effect on bone health. The estimated sc-8 PM cut-point value, 3.62 nmol/L, corresponds to normal published values (34) and is only slightly higher than mean value for our cohort (3.4 nmol/L). One population study using the same chemoluminescence assay as ours measured values of 2.0 61.8 nmol/L (range 0.0 to 13.1) at 10 PM in both men and women 50 to 69 years old, after exclusion of values .3 SD over the mean (38) . Our mean value in a comparable population of only women is slightly higher (3.4 nmol/L) with a similar range of values (0.3 to 22.5). The differences could be explained by the fact that we only excluded values .4 SD over the mean and that had been measured 2 hours before, which may be a significant delay, as the real cortisol nadir happens shortly after sleeping.
Strengths of our study are mostly related to its size and homogeneity, with a very exhaustive phenotypization of risk factors for fracture. Weaknesses concern salivary cortisol measures, as we dispose of only one measure per time-point per participant, as well as the cross-sectional design of the study. Moreover, evening value has not been measured at the hour usually used for Cushing's diagnosis, to facilitate compliance to saliva collection.
In conclusion, increased values of salivary cortisol in the evening are independently associated with lower TBS values and increased prevalence of radiologic VFx in postmenopausal women, independent of age and lumbar spine BMD as well as major clinical risk factors. Increased risk of VFx in women with high level of sc-8 PM is only partially mediated by low microarchitecture as assessed by TBS. If other studies confirm a partially independent association of increased evening salivary cortisol and low TBS in regard to VFx risk, measurement of salivary cortisol in the evening could become an additional interesting parameter to further assess fracture risk.
